Publicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (14)

2024

  1. A multilayer network analysis of Alzheimer's disease pathogenesis: Roles for p-tau, synaptic peptides, and physical activity

    Alzheimer's and Dementia

  2. Effect of antipsychotic drugs on group II metabotropic glutamate receptor expression and epigenetic control in postmortem brains of schizophrenia subjects

    Translational Psychiatry, Vol. 14, Núm. 1

  3. New Origins of Yeast, Plant and Bacterial-Derived Extracellular Vesicles to Expand and Advance Compound Delivery

    International Journal of Molecular Sciences, Vol. 25, Núm. 13

  4. Next-Generation Proteomics of Brain Extracellular Vesicles in Schizophrenia Provide New Clues on the Altered Molecular Connectome

    Biomedicines, Vol. 12, Núm. 1

  5. Permissive epigenetic regulatory mechanisms at the histone level are enhanced in postmortem dorsolateral prefrontal cortex of individuals with schizophrenia

    Journal of Psychiatry and Neuroscience, Vol. 49, Núm. 1, pp. E35-E44

2023

  1. Regulation of Cortico-Thalamic JNK1/2 and ERK1/2 MAPKs and Apoptosis-Related Signaling Pathways in PDYN Gene-Deficient Mice Following Acute and Chronic Mild Stress

    International journal of molecular sciences, Vol. 24, Núm. 3

2021

  1. Effects of Gαi2 and Gαz protein knockdown on alpha2A-adrenergic and cannabinoid CB1 receptor regulation of MEK-ERK and FADD pathways in mouse cerebral cortex

    Pharmacological Reports, Vol. 73, Núm. 4, pp. 1122-1135

2019

  1. The SNAP25 Interactome in Ventromedial Caudate in Schizophrenia Includes the Mitochondrial Protein ARF1

    Neuroscience, Vol. 420, pp. 97-111

  2. The synaptic pathology of cognitive life

    Dialogues in Clinical Neuroscience, Vol. 21, Núm. 3, pp. 271-279

2013

  1. Cyclin-dependent kinase-5 and p35/p25 activators in schizophrenia and major depression prefrontal cortex: Basal contents and effects of psychotropic medications

    International Journal of Neuropsychopharmacology, Vol. 16, Núm. 3, pp. 683-689

2012

  1. Regulation of munc18-1 and syntaxin-1A interactive partners in schizophrenia prefrontal cortex: Down-regulation of munc18-1a isoform and 75 kDa SNARE complex after antipsychotic treatment

    International Journal of Neuropsychopharmacology, Vol. 15, Núm. 5, pp. 573-588

2010

  1. Reduced platelet G protein-coupled receptor kinase 2 in major depressive disorder: Antidepressant treatment-induced upregulation of GRK2 protein discriminates between responder and non-responder patients

    European Neuropsychopharmacology, Vol. 20, Núm. 10, pp. 721-730

2009

  1. Phosphorylation of FADD (Fas-associated death domain protein) at serine 194 is increased in the prefrontal cortex of opiate abusers: Relation to mitogen activated protein kinase, phosphoprotein enriched in astrocytes of 15 kDa, and Akt signaling pathways involved in neuroplasticity

    Neuroscience, Vol. 161, Núm. 1, pp. 23-38

2008

  1. Regulation of the extrinsic and intrinsic apoptotic pathways in the prefrontal cortex of short- and long-term human opiate abusers

    Neuroscience, Vol. 157, Núm. 1, pp. 105-119